chrX-15549831-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_203281.3(BMX):c.1796-9G>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,194,541 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 49 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., 10 hem., cov: 22)
Exomes 𝑓: 0.00011 ( 0 hom. 39 hem. )
Consequence
BMX
NM_203281.3 splice_polypyrimidine_tract, intron
NM_203281.3 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.00002348
2
Clinical Significance
Conservation
PhyloP100: -0.735
Genes affected
BMX (HGNC:1079): (BMX non-receptor tyrosine kinase) This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-15549831-G-C is Benign according to our data. Variant chrX-15549831-G-C is described in ClinVar as [Benign]. Clinvar id is 739305.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 10 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BMX | NM_203281.3 | c.1796-9G>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000348343.11 | |||
BMX | NM_001320866.2 | c.1793-9G>C | splice_polypyrimidine_tract_variant, intron_variant | ||||
ACE2 | NM_001386259.1 | c.2309+14193C>G | intron_variant | ||||
BMX | NM_001721.7 | c.1796-9G>C | splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BMX | ENST00000348343.11 | c.1796-9G>C | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_203281.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000143 AC: 16AN: 111584Hom.: 0 Cov.: 22 AF XY: 0.000296 AC XY: 10AN XY: 33768
GnomAD3 genomes
AF:
AC:
16
AN:
111584
Hom.:
Cov.:
22
AF XY:
AC XY:
10
AN XY:
33768
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000248 AC: 42AN: 169661Hom.: 0 AF XY: 0.000285 AC XY: 16AN XY: 56091
GnomAD3 exomes
AF:
AC:
42
AN:
169661
Hom.:
AF XY:
AC XY:
16
AN XY:
56091
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 118AN: 1082903Hom.: 0 Cov.: 30 AF XY: 0.000111 AC XY: 39AN XY: 351343
GnomAD4 exome
AF:
AC:
118
AN:
1082903
Hom.:
Cov.:
30
AF XY:
AC XY:
39
AN XY:
351343
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000143 AC: 16AN: 111638Hom.: 0 Cov.: 22 AF XY: 0.000296 AC XY: 10AN XY: 33832
GnomAD4 genome
AF:
AC:
16
AN:
111638
Hom.:
Cov.:
22
AF XY:
AC XY:
10
AN XY:
33832
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at